<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chang TY</submitter><funding>National Science Council</funding><pagination>156356</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3966419</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2014</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The most common gene-based cancer therapies involve the suppression of oncogenic molecules and enhancement of the expression of tumor-suppressor genes. Studies in noncancer disease animal models have shown that minicircle (MC) DNA vectors are easy to deliver and that the proteins from said MC-carrying DNA vectors are expressed over a long period of time. However, delivery of therapeutic genes via a liposome-mediated, MC DNA complex has never been tested in vascular-rich hepatocellular carcinoma (HCC). Liposome-mediated DNA delivery exhibits high in vivo transfection efficiency and minimal systemic immune response, thereby allowing for repetitive interventions. In this study, we evaluated the efficacy of delivering an MC-liposome vector containing a 3.2 kb androgen recept</pubmed_abstract><journal>BioMed research international</journal><pubmed_title>Durable expression of minicircle DNA-liposome-delivered androgen receptor cDNA in mice with hepatocellular carcinoma.</pubmed_title><pmcid>PMC3966419</pmcid><funding_grant_id>NSC101-2314-B-039-027-MY3</funding_grant_id><pubmed_authors>Chuang WM</pubmed_authors><pubmed_authors>Chung CY</pubmed_authors><pubmed_authors>Jeng LB</pubmed_authors><pubmed_authors>Ma WL</pubmed_authors><pubmed_authors>Chang TY</pubmed_authors><pubmed_authors>Li LY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Durable expression of minicircle DNA-liposome-delivered androgen receptor cDNA in mice with hepatocellular carcinoma.</name><description>&lt;h4>Background&lt;/h4>The most common gene-based cancer therapies involve the suppression of oncogenic molecules and enhancement of the expression of tumor-suppressor genes. Studies in noncancer disease animal models have shown that minicircle (MC) DNA vectors are easy to deliver and that the proteins from said MC-carrying DNA vectors are expressed over a long period of time. However, delivery of therapeutic genes via a liposome-mediated, MC DNA complex has never been tested in vascular-rich hepatocellular carcinoma (HCC). Liposome-mediated DNA delivery exhibits high in vivo transfection efficiency and minimal systemic immune response, thereby allowing for repetitive interventions. In this study, we evaluated the efficacy of delivering an MC-liposome vector containing a 3.2 kb androgen recept</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014</publication><modification>2025-04-04T08:41:24.921Z</modification><creation>2019-03-27T01:23:59Z</creation></dates><accession>S-EPMC3966419</accession><cross_references><pubmed>24734226</pubmed><doi>10.1155/2014/156356</doi></cross_references></HashMap>